Simon Estcourt, Senior Vice President – Strategy & Corporate Development at Idis, presented at last year's World Orphan Drug Congress USA on the topic âManaging patients globally: Considerations for developing robust orphan drug business models that create ethical access.'
Do you want to learn more about:
- Evolving ethical and commercial drivers in rare disease business considerations
- Benefits of early strategic planning for global managed access to appropriately address needs of emerging and established markets
- Successfully providing equitable access through global managed access strategies in pre-launch phase and post-launch
If so, you need to check out the video below: